Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

4.900 -0.280 (-5.41%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 09, 2023

Via Benzinga

Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings ↗

November 09, 2023

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53....

Via Benzinga

Topics Stocks

US Stocks Mostly Flat; Jobless Claims Decline In Latest Week ↗

November 09, 2023

U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Following the market opening Thursday, the Dow traded down 0.02% to 34,105.13 while the NASDAQ rose 0.01% to...

Via Benzinga

Topics Stocks

Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results.

Via Benzinga

Atara Biotherapeutics's Earnings Outlook ↗

August 07, 2023

Via Benzinga

Astra Space (ASTR) Stock Spikes 82% on Take-Private Proposal ↗

November 09, 2023

Astra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders.

Via InvestorPlace

Why Is Assertio (ASRT) Stock Down 39% Today? ↗

November 09, 2023

Assertio stock is dropping on Thursday as investors in ASRT react to the company's poor earnings results for the third quarter of 2023.

Via InvestorPlace

Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today? ↗

November 09, 2023

Atara Biotherapeutics stock is falling on Thursday as investors in ATRA react to the company's latest Phase 2 clinical trial data.

Via InvestorPlace

Why Atara Biotherapeutics Shares Are Plummeting Today ↗

November 09, 2023

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 09, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 09, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping tabs on for Thursday morning!

Via InvestorPlace

Atara Biotherapeutics Announces Primary Analysis Data from Phase 2 EMBOLD Clinical Trial of ATA188 in Non-Active Progressive Multiple Sclerosis

November 08, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Announces Expanded Global Tab-cel® Partnership with Pierre Fabre Laboratories and Third Quarter 2023 Financial Results

November 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

10 Health Care Stocks Whale Activity In Today's Session ↗

October 10, 2023

Via Benzinga

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 06, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

September 20, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.

Via Benzinga

Atara Biotherapeutics Announces Plans to Submit Tab-cel® BLA in Q2 2024 Following FDA Agreement on Comparability

September 19, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in Cell Therapies in Autoimmune Panel Discussion at the Citi 18th Annual BioPharma Conference

August 31, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 08, 2023

Via Benzinga

Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

August 08, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 04, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023

August 01, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference

July 31, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

3 Doomed Biotech Stocks Destined for Disaster ↗

July 17, 2023

Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.

Via InvestorPlace

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 07, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

June 07, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023

June 05, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 02, 2023

From Atara Biotherapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.